No abstract available
Keywords:
Cell signaling pathways; Morphoproteomics; Refractory; Resistance; Resistant.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology
-
Bevacizumab / administration & dosage
-
Bevacizumab / pharmacology
-
Capecitabine / administration & dosage
-
Capecitabine / pharmacology
-
Carcinoma, Renal Cell / drug therapy*
-
Carcinoma, Renal Cell / genetics
-
Carcinoma, Renal Cell / metabolism
-
Humans
-
Kidney Neoplasms / drug therapy*
-
Kidney Neoplasms / genetics
-
Kidney Neoplasms / metabolism
-
Male
-
Mechanistic Target of Rapamycin Complex 2
-
Middle Aged
-
Multiprotein Complexes / genetics
-
Multiprotein Complexes / metabolism
-
Neoplasm Metastasis
-
Organoplatinum Compounds / administration & dosage
-
Organoplatinum Compounds / pharmacology
-
Oxaliplatin
-
Proteomics / methods*
-
Sequence Analysis, DNA / methods*
-
Signal Transduction
-
TOR Serine-Threonine Kinases / genetics
-
TOR Serine-Threonine Kinases / metabolism
-
Treatment Outcome
Substances
-
Multiprotein Complexes
-
Organoplatinum Compounds
-
Oxaliplatin
-
Bevacizumab
-
Capecitabine
-
Mechanistic Target of Rapamycin Complex 2
-
TOR Serine-Threonine Kinases